ZZZhihong Zhang

Zhihong Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhihong Zhang has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Ali Zolnour

    Columbia University Irving Medical Center, New York, NY 10032, United States

    2 shared publications
  • Maryam Zolnoori

    Data Science Institute, Columbia University, New York, NY 10027, United States; Columbia University Irving Medical Center, New York, NY 10032, United States

    2 shared publications
  • Maxim Topaz

    Data Science Institute, Columbia University, New York, NY 10027, United States; School of Nursing, Columbia University, New York, NY 10032, United States

    2 shared publications
  • Mohamad Javad Momeni Nezhad

    Columbia University Irving Medical Center, New York, NY 10032, United States

    2 shared publications
  • Hans Moen

    Department of Computer Science, Aalto University, Espoo, Uusimaa, Finland

    1 shared publication
  • Hossein Azadmaleki

    Columbia University Irving Medical Center, New York, NY 10032, USA

    1 shared publication

Latest Publications

  • Advancing healthcare with large language models: A scoping review of applications and future directions

    by Zhihong Zhang, Mohamad Javad Momeni Nezhad, Seyed Mohammad Bagher Hosseini, Ali Zolnour, Zahra Zonour, Seyedeh Mahdis Hosseini, Maxim Topaz, Maryam Zolnoori


  • Enhancing AI for citation screening in literature reviews: Improving accuracy with ensemble models

    by Zhihong Zhang, Mohamad Javad Momeni Nezhad, Pallavi Gupta, Ali Zolnour, Hossein Azadmaleki, Maxim Topaz, Maryam Zolnoori


  • Toward equitable documentation: Evaluating ChatGPT’s role in identifying and rephrasing stigmatizing language in electronic health records

    by Zhihong Zhang, Jihye Kim Scroggins, Sarah Harkins, Ismael Ibrahim Hulchafo, Hans Moen, Michele Tadiello, Veronica Barcelona, Maxim Topaz


  • Time series analysis of impact of COVID-19 on infant and neonatal mortality in the United States

    by Zhihong Zhang, Jiebo Luo

    Background This study aims to conduct a time series analysis to assess the effect of COVID-19 on infant and neonatal mortality in its first three years. Methods Linked infant birth and death certificate data from the United States between 2016 and 2022 were used. Long Short-Term Memory (LSTM) and Autoregressive Integrated Moving Average (ARIMA)/ARIMA with Exogenous Variables (ARIMAX) were employed to predict monthly infant and neonatal mortality trends in 2022 with and without incorporating COVID-19 as a feature. Interrupted Time Series Analysis was conducted to measure monthly rate changes before (pre-March 2020) and during the COVID-19 period (March 2020–December 2022). Results Infant and neonatal deaths declined from 2016 to 2020/2021, with increases observed starting in May 2022. Incorporating COVID-19 as a variable into prediction models reduced the predictive performance of both LSTM and ARIMA/ARIMAX models. Compared to the pre-COVID-19 period, ITS showed no significant changes in monthly infant and neonatal death rates. However, significant increases were noted in low birth weight, low Apgar scores, and infrequent prenatal visits during 2021-2022. Conclusion COVID-19 altered the previously continuous decline in infant and neonatal deaths in 2022. Despite this late increase, the overall impact of COVID-19 on infant and neonatal mortality remains minimal. Impact Infant and neonatal deaths showed a steady decline from 2016 through 2020/2021. However, an increase in infant and neonatal deaths emerged in the later stages of the COVID-19 pandemic (2022). Rates of risk factors associated with infant and neonatal deaths, such as low birth weight and inadequate prenatal care, increased during the COVID-19 period. Understanding the shifts in infant and neonatal mortality and related risk factors during the COVID-19 pandemic provides valuable insights into its impact and enhances preparedness for future pandemics.


  • A scoping review of resilience in adults with cancer based on the NIH resilience concept model

    by Zhihong Zhang, Marie A. Flannery, Kathi L. Heffner

    Purpose The NIH Resilience Concept Model (NIH-RCM) is a comprehensive model that conceptualizes resilience through three components: challenge or stressor, system, and the system’s responses, providing a clear definition and measurement approach for resilience research. This scoping review uses the NIH-RCM as a framework to organize and summarize research on resilience in adults with cancer, especially those aged 65 + , and identify research gaps. Methods A systematic search of PubMed, CINAHL, PsycINFO, and Web of Science was conducted to identify studies that examined resilience in the individual domain of adults (including those ≥ 65 years) with cancer from inception to July 2022. Included studies were organized into the components (stressor, system, and responses), definition, and measures of resilience. Results Eighty-nine studies were included. Most (88%) studies included adults of all ages, with only ten focusing exclusively on older adults. Of the 89 studies, 78% identified cancer-related events as stressors, and 94% of studies identified the individual psychosocial system as the system affected by the stressor and measured the system’s responses within the psychosocial subdomain. Several resilience definitions were identified from 60% of studies, with 44% conceptualizing resilience as an ability. Five types of resilience measures were identified in 99% of studies, with 15% measuring resilience by comparing pre- and post-stressor changes in the system’s responses. Conclusions There was a range of definitions and measures for resilience. Gaps in research include a minimal focus on older adults with cancer and individuals’ physiological and molecular/genetic systems and their responses within these subdomains.